Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Juan, PR
NPI
1932357092
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
San Jorge Medical Building, 252 Calle San Jorge Ste 301
San Juan, PR, 00912
Phone (787) 729-7777
Medicare paid, 2024
$14K
295 services
Medicare patients, 2024
113
Average age 77
Drug cost, 2024
$2.7M
15,415 prescriptions
Company payments, 2025
$306
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael Trinidad Hernandez was code 99213 (office e&m - established), 138 times for 63 patients. In total Rafael Trinidad Hernandez billed 295 services in 7 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 138 | 63 | $55.74 | $7,692 |
| 99231 Hospital E&M - Subsequent | Facility | 117 | 41 | $30.03 | $3,514 |
| 99221 Hospital E&M - Initial | Facility | 26 | 26 | $64.07 | $1,666 |
By year: 2022 $13K for 246 services; 2023 $15K for 312 services; 2024 $14K for 295 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rafael Trinidad Hernandez prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 2,238 prescriptions and refills. In total Rafael Trinidad Hernandez wrote 15,415 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 2,238 | 3,245 | 379 | $155K |
| Atorvastatin Calcium Generic | 1,486 | 2,383 | 352 | $14K |
| Farxiga Dapagliflozin Propanediol | 810 | 974 | 164 | $568K |
| Metformin Hcl Generic | 785 | 1,220 | 163 | $5,453 |
| Rosuvastatin Calcium Generic | 777 | 1,240 | 179 | $11K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 496 | 600 | 90 | $56K |
| Glimepiride Generic | 436 | 659 | 101 | $5,849 |
| Ezetimibe Generic | 429 | 622 | 103 | $6,162 |
| Gabapentin Generic | 418 | 577 | 88 | $4,312 |
| Levothyroxine Sodium Generic | 396 | 641 | 80 | $4,540 |
| Losartan Potassium Generic | 355 | 554 | 80 | $2,962 |
| Jardiance Empagliflozin | 310 | 370 | 64 | $225K |
| Alendronate Sodium Generic | 305 | 405 | 62 | $2,215 |
| Fenofibrate Generic | 287 | 451 | 76 | $6,409 |
| Humalog Insulin Lispro | 275 | 320 | 52 | $42K |
Brand drugs: 6,028 claims; generic drugs: 8,696 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael Trinidad Hernandez $306 ($306 in general payments such as food, travel and fees) from 5 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $120.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.